SEC Filings TLDR

On August 4, 2025, Michael Bondi, the Chief Financial Officer of Comtech Telecommunications Corp., engaged in several transactions involving the company's securities. Bondi vested 1,810 restricted stock units (RSUs) that were issued to him on August 4, 2020, converting them into common stock on a one-for-one basis. Thi...

On August 5, 2025, Ian Whinnem, the Senior Vice President and Chief Financial Officer (CFO) of CIVISTA BANCSHARES, INC., acquired 1,500 shares of the company's common stock at a price of $19.20 per share. Following this transaction, Whinnem's total holdings in the company increased to 2,500 shares. The transaction was ...

On August 1, 2025, Charter Communications, Inc. granted stock options and restricted stock units to Richard J. DiGeronimo, the President of Product & Technology. The stock options, totaling 8,065 shares of Class A Common Stock, were granted under the company's 2019 Stock Incentive Plan. These options will vest on Augus...

On August 5, 2025, Loren D. Cole, EVP & CIO of Chemung Financial Corp (CHMG), filed a Form 4 with the SEC. The filing reports transactions involving the company's common stock. Cole directly owns 5,742 shares and indirectly owns 105 shares through his spouse. Additionally, Cole acquired 2,983 shares through a qualified...

Matthew Moschner, CEO & President of Cognex Corp, reported several stock transactions on August 4, 2025. These included the vesting of restricted stock units (RSUs) and the sale of shares to cover tax obligations. Specifically, 3,441 RSUs vested, and 1,010 shares were sold at $41.43 per share to satisfy tax withholding...

Paul Cunningham, Sr. Vice President of Cadence Design Systems Inc., sold 1,000 shares of the company's common stock on August 1, 2025, at a price of $358.72 per share. This transaction was executed under a Rule 10b5-1 Trading Plan adopted on March 14, 2025. Following the sale, Cunningham owns 104,499 shares of the comp...

Jeffrey Adam Novack, Secretary and General Counsel of CareDx, Inc., filed a Form 4 with the SEC on August 5, 2025, reporting a transaction on August 1, 2025. Novack disposed of 2,873 shares of common stock at a price of $12.22 per share, resulting in a total transaction value of $35,108.06. These shares were withheld b...

Abhishek Jain, the Chief Financial Officer of CareDx, Inc., filed a Form 4 with the SEC on August 5, 2025. The filing reports a transaction on August 1, 2025, where Jain disposed of 7,687 shares of common stock at a price of $12.22 per share. These shares were withheld by the issuer to satisfy tax withholding obligatio...

Elshareef Ismail, the Chief Product Officer of CarGurus, Inc., reported two transactions involving Class A Common Stock. On August 1, 2025, Ismail disposed of 2,299 shares at a price of $31.86 per share, resulting in a total transaction value of $73,246.14. This transaction was related to shares withheld for payment of...

On August 1, 2025, Javier Zamora, the General Counsel and Secretary of CarGurus, Inc., disposed of 1,880 shares of Class A Common Stock at a price of $31.86 per share. This transaction was related to the withholding of shares for the payment of tax liability upon the vesting of restricted stock units. Following this tr...

On August 1, 2025, Samuel Zales, the COO and President of CarGurus, Inc., sold 10,000 shares of Class A Common Stock at a price of $32.29 per share. This transaction was executed pursuant to a Rule 10b5-1 trading plan, which allows company insiders to sell shares at predetermined times to avoid accusations of insider t...

Ryan J. Hildebrand, Chief Innovation Officer of Bankwell Financial Group, Inc., reported transactions involving the company's common stock. On August 4, 2025, Hildebrand disposed of 2,051 shares at a price of $39.69 per share. Following this transaction, he no longer holds any shares. Hildebrand also holds 15,000 share...

On August 1, 2025, BioXcel Therapeutics, Inc. (BTAI) granted 9,000 Restricted Stock Units (RSUs) to Richard I. Steinhart, the company's Chief Financial Officer. Each RSU represents a contingent right to receive one share of the company's Common Stock. The RSUs are set to vest 100% on or within thirty days of May 1, 202...

On August 1, 2025, Javier Rodriguez, Chief Legal Officer, Senior Vice President, and Corporate Secretary of BioXcel Therapeutics, Inc., was granted 9,000 Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of the company's Common Stock. The RSUs are set to vest 100% on or within t...

On August 1, 2025, BioXcel Therapeutics, Inc. (BTAI) granted 9,000 Restricted Stock Units (RSUs) to Frank Yocca, Ph.D., the company's Chief Scientific Officer. Each RSU represents a contingent right to receive one share of the company's Common Stock. The RSUs are set to vest 100% on or within thirty days of 9 months fr...

On August 1, 2025, Vimal Mehta, the CEO and President of BioXcel Therapeutics, Inc., was granted 18,000 Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of the company's Common Stock. The RSUs are set to vest 100% on or within thirty days of 9 months from the Grant Date, which ...

On August 1, 2025, David R. Shaman, the Chief Legal Officer of Bentley Systems Inc, reported transactions involving Class B Common Stock. The transactions included the disposal of 1,201 shares at a price of $57.12 per share. These shares were withheld by the Issuer to cover taxes due by the Reporting Person upon a sche...

On August 2, 2025, William C. Tsonos, CEO of Bank Rhode Island, reported multiple transactions involving Brookline Bancorp Inc. common stock. Tsonos disposed of 380 shares at $10.28 per share, reducing his holdings to 48,285 shares. He also disposed of 127 shares at the same price, bringing his total to 48,158 shares. ...

Marissa S. Martin, General Counsel of Brookline Bancorp, Inc., reported several transactions involving the company's common stock on August 2, 2025. These transactions included the disposal of shares at a price of $10.28 per share. Specifically, Martin disposed of 1,596 shares, reducing her holdings to 42,754 shares. S...

On August 2, 2025, Janytra M. Brooks, Chief Human Resources Officer of Brookline Bancorp, Inc., reported multiple transactions involving the company's common stock. Brooks sold a total of 3,763 shares at a price of $10.28 per share. The transactions included the sale of 1,596 performance-based restricted stock shares, ...

On August 2, 2025, Carl M. Carlson, Co-President & CFO of Brookline Bancorp Inc., reported several transactions involving the company's common stock. Carlson disposed of shares in multiple transactions, each at a price of $10.28 per share. The transactions included the disposal of 2,876 shares, 959 shares, 1,303 shares...

On August 2, 2025, Darryl J. Fess, CEO of Brookline Bank, reported several transactions involving the common stock of Brookline Bancorp, Inc. (BRKL). Fess disposed of a total of 4,996 shares at a price of $10.28 per share. These transactions included the disposal of 1,978 performance-based restricted stock shares, whic...

On August 2, 2025, Michael W. McCurdy, Co-President & COO of Brookline Bancorp Inc, reported several transactions involving the company's common stock. McCurdy disposed of shares in multiple transactions, totaling 6,578 shares at a price of $10.28 per share. These transactions were reported on Form 4 and included perfo...

Mark J. Meiklejohn, Chief Credit Officer of Brookline Bancorp Inc., reported multiple transactions involving the company's common stock on August 2, 2025. The transactions included the disposition of shares at a price of $10.28 per share. Specifically, Meiklejohn disposed of 1,869 shares, 623 shares, 1,059 shares, and ...

Michael P. Goldrick, CEO of PCSB Bank, reported two transactions involving the common stock of Brookline Bancorp Inc (BRKL) on August 2, 2025. In the first transaction, he disposed of 996 shares at a price of $10.28 per share, reducing his direct ownership to 48,681 shares. In the second transaction, he disposed of an ...